Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: 3-Year Results from the ALLEGRO-LT Phase 3, Open-Label Study. J of Skin 2025, 9 (4), s582. https://doi.org/10.25251/gdd40x24.